|Bid||54.49 x 800|
|Ask||56.15 x 2200|
|Day's Range||54.72 - 57.46|
|52 Week Range||30.02 - 58.72|
|Beta (5Y Monthly)||1.43|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17, 2020, at 3:20 p.m. Eastern Time.
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its financial results for the third quarter ended September 30, 2020.
NEW YORK, NY / ACCESSWIRE / November 4, 2020 / ACADIA Pharmaceuticals, Inc.